Loading...
Drug Pricing Reforms And Patent Expiry Will Constrain Outcomes
n/a
n/a
AnalystLowTarget's Fair Value
n/a
1Y
25.7%7D
-4.5%1Y
25.7%7D
-4.5%You can edit this narrative until May 12 6:02 AM. Then, changes will post as Updates.
You can edit this narrative until May 12 6:02 AM. Then, changes will post as Updates.